GSK (GSK)

Up
Share Price:
1,855.00p
Market Cap:
£75,043m
Change Today:
41.00p
Sector:
Pharma and Biotech

Latest ShareCast News

GSK Q3 sales rise as specialty medicines drive growth

By Benjamin Chiou

Date: Wednesday 28 Oct 2026

(Sharecast News) - GSK reported a 5% increase in third-quarter sales on Wednesday, driven by strong growth in specialty medicines, as the pharmaceutical giant reaffirmed its full-year guidance.

GSK reports encouraging data in ovarian and rectal cancer studies

By Iain Gilbert

Date: Monday 26 Oct 2026

(Sharecast News) - Drugmaker GSK reported two sets of encouraging cancer‑drug results on Monday, with fresh data for its experimental ovarian‑cancer therapy Mo‑Rez and new interim findings for Jemperli in rectal cancer, both due to be presented at the ESMO Congress.

GSK secures US approval for hepatitis B drug Hibsago

By Iain Gilbert

Date: Wednesday 21 Oct 2026

(Sharecast News) - Drugmaker GSK said on Wednesday that the US Food and Drug Administration had approved Hibsago (bepirovirsen) for the treatment of chronic hepatitis B in adults without cirrhosis, marking the first approval of an antisense oligonucleotide for the disease.

GSK's Ris‑Rez shows 61pc response rate in ... 19-Oct-2026
Berenberg upgrades GSK to 'buy', raises target p... 15-Sep-2026
GSK acquires global rights to multiple myeloma a... 15-Sep-2026
GSK highlights pipeline momentum with Ris‑... 14-Sep-2026
GSK gets Japanese approval for new ready‑t... 10-Sep-2026
GSK advances mRNA flu shot after Phase II success 01-Sep-2026
GSK notches major regulatory milestones in Japan... 24-Aug-2026
GSK launches £2bn cost savings drive, confirms ... 28-Jul-2026
GSK secures EMA review for single‑dose Bex... 20-Jul-2026
GSK shares fall as cough drug development axed 17-Jul-2026
GSK rectal cancer drug shows positive result in ... 13-Jul-2026
GSK hails 'milestone' drug trial results in China 10-Jul-2026
GSK's momelotinib receives orphan drug designati... 12-Jun-2026
GSK to buy Boston-based biopharma firm Nuvalent ... 09-Jun-2026
Trials show GSK drug cures hepatitis B in nearly... 28-May-2026
Citi sees buying opportunity at AstraZeneca afte... 18-May-2026
GSK strikes agreement with China's SBP Group, la... 11-May-2026
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

GSK Market Data

Currency UK Pounds
Price 1,855.00p
Change Today 41.00p
52 Week High 2,208.00p
52 Week Low 1,735.50p
Volume 13,548,350
Shares Issued 4,045.43m
Market Cap £75,043m

Performance Indicators

Compare performance with the sector and the market.

Key
Vs Market
Vs Sector
Value
market
  1. half market star
  2. empty market
  3. empty market
  4. empty market
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. half sector star
  4. empty sector
  5. empty sector
Price Trend
market
  1. full market star
  2. full market star
  3. full market star
  4. full market star
  5. half market star
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. full sector star
  5. empty sector
Income
market
  1. full market star
  2. full market star
  3. full market star
  4. empty market
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. half sector star
  5. empty sector
Growth
market
  1. full market star
  2. full market star
  3. full market star
  4. half market star
  5. empty market
sector
  1. full sector star
  2. empty sector
  3. empty sector
  4. empty sector
  5. empty sector
Price Chg 6m
market
  1. full market star
  2. full market star
  3. full market star
  4. full market star
  5. half market star
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. full sector star
  5. half sector star
P/E
market
  1. full market star
  2. full market star
  3. full market star
  4. half market star
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. half sector star
  5. empty sector
PEG
market
  1. full market star
  2. empty market
  3. empty market
  4. empty market
  5. empty market
sector
  1. empty sector
  2. empty sector
  3. empty sector
  4. empty sector
  5. empty sector
Dividend Yield
market
  1. full market star
  2. full market star
  3. half market star
  4. empty market
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. empty sector
  5. empty sector
EPS Growth
market
  1. full market star
  2. full market star
  3. full market star
  4. empty market
  5. empty market
sector
  1. full sector star
  2. half sector star
  3. empty sector
  4. empty sector
  5. empty sector
Operating Margin
market
  1. full market star
  2. full market star
  3. full market star
  4. half market star
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. full sector star
  5. half sector star

What The Brokers Say

Strong Buy 4
Buy 3
Neutral 12
Sell 2
Strong Sell 0
Total 21
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.